---
figid: PMC3507479__cc-11-3909-g1
figtitle: An expanded role of the tumor suppressor TSC1 in T cell tolerance
organisms:
- NA
pmcid: PMC3507479
filename: cc-11-3909-g1.jpg
figlink: /pmc/articles/PMC3507479/figure/F1/
number: F1
caption: Figure 1. TSC1/2-mTOR signaling in T cell activation and tolerance. TCR engagement
  activates PLCγ1, which hydrolyzes PIP2 to generate DAG and IP3, two important second
  messengers that trigger the activation of multiple signal cascades. IP3 triggers
  Ca2+ influx, which, in turn, induces the activation of the calcineurin-NFAT pathway.
  DAG associates and activates RasGRP1 and PKCθ, resulting in the activation of the
  Ras-Erk1/2-AP1 and IKK-NFκB pathways, respectively. CD28 provides costimulation
  and enhances PI3K-Akt activation. The Ca2+-NFAT pathway alone induces T cell anergy
  by increasing expression of anergy-promoting molecules. This pathway, in concert
  with DAG-mediated pathways, induces T cell activation. DGKs convert DAG to PA and,
  thus, inhibit T cell activation. In T cells, the RasGRP1-Ras-Erk1/2 pathway as well
  as the PI3K-Akt pathway, is important for mTORC1 and mTORC2 signaling. TSC1 inhibits
  mTORC1, but promotes mTORC2 signaling and is important for T cell survival, quiescence
  and anergy.
papertitle: An expanded role of the tumor suppressor TSC1 in T cell tolerance.
reftext: Xiao-Ping Zhong. Cell Cycle. 2012 Nov 1;11(21):3909-3910.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9447702
figid_alias: PMC3507479__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3507479__F1
ndex: cfbd201c-deb0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3507479__cc-11-3909-g1.html
  '@type': Dataset
  description: Figure 1. TSC1/2-mTOR signaling in T cell activation and tolerance.
    TCR engagement activates PLCγ1, which hydrolyzes PIP2 to generate DAG and IP3,
    two important second messengers that trigger the activation of multiple signal
    cascades. IP3 triggers Ca2+ influx, which, in turn, induces the activation of
    the calcineurin-NFAT pathway. DAG associates and activates RasGRP1 and PKCθ, resulting
    in the activation of the Ras-Erk1/2-AP1 and IKK-NFκB pathways, respectively. CD28
    provides costimulation and enhances PI3K-Akt activation. The Ca2+-NFAT pathway
    alone induces T cell anergy by increasing expression of anergy-promoting molecules.
    This pathway, in concert with DAG-mediated pathways, induces T cell activation.
    DGKs convert DAG to PA and, thus, inhibit T cell activation. In T cells, the RasGRP1-Ras-Erk1/2
    pathway as well as the PI3K-Akt pathway, is important for mTORC1 and mTORC2 signaling.
    TSC1 inhibits mTORC1, but promotes mTORC2 signaling and is important for T cell
    survival, quiescence and anergy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tcr
  - sl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dgk
  - rdgA
  - Gk2
  - CG34384
  - Pa
  - Pdk1
  - ca
  - ras
  - Ras64B
  - Ras85D
  - gig
  - Tsc1
  - Dsor1
  - Rheb
  - rl
  - Crtc
  - NFAT
  - Dif
  - dl
  - Rel
  - AP-1gamma
  - Jra
  - kay
  - S6k
  - Thor
  - TH1
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - CD28
  - PLCG1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - DGKB
  - DGUOK
  - DGKE
  - DGKA
  - DGKD
  - DGKG
  - DGKH
  - DGKQ
  - DGKZ
  - DGKI
  - DGKK
  - PDK1
  - PDPK1
  - RASGRP1
  - KRAS
  - HRAS
  - NRAS
  - TSC2
  - TSC1
  - CCL26
  - MAP2K2
  - MAP2K1
  - RHEB
  - RHEBP1
  - MAPK3
  - MAPK1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - RPTOR
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - RPS6KB1
  - EIF4EBP1
  - PRKCE
  - EGR2
  - EGR3
  - NELFCD
  - Cancer
---
